Scientists create the first CRISPR-based drug candidate targeting the microbiome
Many people have experienced infections from E. coli, which are primarily seen as inconvenient and unpleasant. For some patients, like those with blood cancer, however, there is a risk that the bacteria will travel into the ...
May 9, 2023
0
10